Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fox

Showing results (1331-1340 of 1,511) with videos related to

Pageof 152
Sort By:
Lancet (London, England)|February 7, 2026
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, multicentre, randomised, controlled, double-blind, non-inferiority trialAmy E Colson, Anthony M Mills, Moti N Ramgopal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 6, 2011
Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairmentGloria C Chiang, Philip S Insel, Duygu Tosun, et al.
Neurobiology of Aging|September 28, 2015
Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's diseaseNatalie S Ryan, Geert-Jan Biessels, Lois Kim, et al.
ACS Omega|September 29, 2025
Mutasynthesis of C17- and C21-Substituted Ansamitocins for Use as ADC PayloadsAnna E Stanley-Smith, Nigel Coates, James C Fox, et al.
Nature|January 20, 2012
Genetic contributions to stability and change in intelligence from childhood to old ageIan J Deary, Jian Yang, Gail Davies, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 22, 2020
Amyloid β influences the relationship between cortical thickness and vascular loadThomas D Parker, David M Cash, Christopher A Lane, et al.
Best Practice & Research. Clinical Haematology|December 13, 2023
The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes RegistryLucy C Fox, Zoe K McQuilten, Frank Firkin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 10, 2025
Early increase of the synaptic blood marker β-synuclein in asymptomatic autosomal dominant Alzheimer's diseasePatrick Oeckl, Benjamin Mayer, Randall J Bateman, et al.
Frontiers in Neurology|August 22, 2017
Eyetracking Metrics in Young Onset Alzheimer's Disease: A Window into Cognitive Visual FunctionsIvanna M Pavisic, Nicholas C Firth, Samuel Parsons, et al.
Health Technology Assessment (Winchester, England)|February 27, 2013
Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapineS Banerjee, J Hellier, R Romeo, et al.
Pageof 152

Showing results (1331-1340 of 1,511) with videos related to

Sort By:
Pageof 152
Lancet (London, England)|February 7, 2026
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, multicentre, randomised, controlled, double-blind, non-inferiority trialAmy E Colson, Anthony M Mills, Moti N Ramgopal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 6, 2011
Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairmentGloria C Chiang, Philip S Insel, Duygu Tosun, et al.
Neurobiology of Aging|September 28, 2015
Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's diseaseNatalie S Ryan, Geert-Jan Biessels, Lois Kim, et al.
ACS Omega|September 29, 2025
Mutasynthesis of C17- and C21-Substituted Ansamitocins for Use as ADC PayloadsAnna E Stanley-Smith, Nigel Coates, James C Fox, et al.
Nature|January 20, 2012
Genetic contributions to stability and change in intelligence from childhood to old ageIan J Deary, Jian Yang, Gail Davies, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 22, 2020
Amyloid β influences the relationship between cortical thickness and vascular loadThomas D Parker, David M Cash, Christopher A Lane, et al.
Best Practice & Research. Clinical Haematology|December 13, 2023
The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes RegistryLucy C Fox, Zoe K McQuilten, Frank Firkin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 10, 2025
Early increase of the synaptic blood marker β-synuclein in asymptomatic autosomal dominant Alzheimer's diseasePatrick Oeckl, Benjamin Mayer, Randall J Bateman, et al.
Frontiers in Neurology|August 22, 2017
Eyetracking Metrics in Young Onset Alzheimer's Disease: A Window into Cognitive Visual FunctionsIvanna M Pavisic, Nicholas C Firth, Samuel Parsons, et al.
Health Technology Assessment (Winchester, England)|February 27, 2013
Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapineS Banerjee, J Hellier, R Romeo, et al.
Pageof 152